Conditions of publication
Agree to conditions of submission, BioMed Central's copyright and license agreement and article-processing charge (APC)
Copyright and license agreement
During submission, you will need to accept and confirm the following conditions:
- All authors of the manuscript have read and agreed to its content and are accountable for all aspects of the accuracy and integrity of the manuscript in accordance with ICMJE criteria
- That the article is original, has not already been published in a journal, and is not currently under consideration by another journal
- That you agree to the terms of the BioMed Central Copyright and License Agreement, which we strongly recommend you read and, where applicable, Open Data policy. For authors who are prevented from being the copyright holder (for instance where Crown Copyright applies or researchers are US government employees), BioMed Central can accommodate non-standard copyright lines. If this applies to you, please contact us and provide details of your situation.
For more information see our Copyright and license policy.
An article-processing charge (APC) applies for each article accepted for publication in Journal for ImmunoTherapy of Cancer . For further details please see our article-processing-charge page.
Official journal of
- Editorial Board
- Sign up for article alerts and news from this journal
2017 Journal Metrics
46 days to first decision for reviewed manuscripts only
46 days to first decision for all manuscripts
115 days from submission to acceptance
16 days from acceptance to publication
8.374 - 2-year Impact Factor
1.241 - Source Normalized Impact per Paper (SNIP)
2.798 - SCImago Journal Rank (SJR)
5.85 - Citescore
Social Media Impact